Early experience with the FDA's regulatory review of novel gene therapies

Jeremy Puthumana; Alexander C. Egilman; Reshma Ramachandran; Nida Naushad; Nilay Shah; Joseph Ross

doi:10.1136/bmjebm-2021-111720

Early experience with the FDA's regulatory review of novel gene therapies

Jeremy Puthumana, Alexander C. Egilman, Reshma Ramachandran, Nida Naushad, Nilay Shah, Joseph Ross

Quantitative Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	195-198
Number of pages	4
Journal	BMJ evidence-based medicine
Volume	27
Issue number	4
DOIs	https://doi.org/10.1136/bmjebm-2021-111720
State	Published - Aug 1 2022

Keywords

drug development
drug discovery

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/bmjebm-2021-111720

Cite this

@article{4c1adb14564c48bf9a4956977e9490c9,

title = "Early experience with the FDA's regulatory review of novel gene therapies",

keywords = "drug development, drug discovery",

author = "Jeremy Puthumana and Egilman, {Alexander C.} and Reshma Ramachandran and Nida Naushad and Nilay Shah and Joseph Ross",

year = "2022",

month = aug,

day = "1",

doi = "10.1136/bmjebm-2021-111720",

language = "English (US)",

volume = "27",

pages = "195--198",

journal = "BMJ evidence-based medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Early experience with the FDA's regulatory review of novel gene therapies

AU - Puthumana, Jeremy

AU - Egilman, Alexander C.

AU - Ramachandran, Reshma

AU - Naushad, Nida

AU - Shah, Nilay

AU - Ross, Joseph

PY - 2022/8/1

Y1 - 2022/8/1

KW - drug development

KW - drug discovery

UR - http://www.scopus.com/inward/record.url?scp=85135371790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135371790&partnerID=8YFLogxK

U2 - 10.1136/bmjebm-2021-111720

DO - 10.1136/bmjebm-2021-111720

M3 - Article

C2 - 34635478

AN - SCOPUS:85135371790

SN - 2515-446X

VL - 27

SP - 195

EP - 198

JO - BMJ evidence-based medicine

JF - BMJ evidence-based medicine

IS - 4

ER -

Early experience with the FDA's regulatory review of novel gene therapies

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this